S&P 500
7,226.20
+0.01%
Dow Jones
49,494.60
-0.62%
Nasdaq 100
27,685.40
+0.66%
Russell 2000
2,804.78
-0.02%
FTSE 100
10,364.50
0.00%
Nikkei 225
59,260.50
-0.78%

Investing

Walgreens Reports Drop in Same-store Sales (WAG, ESRX)

Photo of Paul Ausick
By Paul Ausick Published
Follow 24/7 Wall St. on Google
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Pharmacy retailer Walgreens (NYSE: WAG) reported same-store sales for February were down -4.6% compared with February 2011. The number of prescriptions filled at comparable stores also fell, by -9.5%.

The company also said that the decline in prescriptions filled due to the cancellation of Walgreens’ contract with Express Scripts Inc. (NASDAQ: ESRX) totaled -10.7%. In February 2011, Express Scripts comprised 12.6% of Walgreens’ prescriptions.

Total sales for February rose 1.5%, from $5.77 billion to $5.86 billion, primarily due to the effect of the extra leap-year day. The impact of generic sales was also negative, as comparable prescription sales lost -2.2% due to the effects of new generics coming on the market.

Photo of Paul Ausick
About the Author Paul Ausick →

Paul Ausick has been writing for a673b.bigscoots-temp.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.

Continue Reading

Paul Ausick |

Walgreen Margins Drop, Chop Profits

Walgreen reported disappointing second-quarter fiscal 2014 results before markets opened Tuesday morning, though prescription sales and front-end sales were higher.
Paul Ausick |

Walgreen’s Same-Store Sales Dive

Drug store giant Walgreen Co. (NYSE: WAG) announced this morning that November same-store sales fell 6.2% year-over-year, primarily due to…
Paul Ausick |

Walgreen Results Send Shares Sliding

courtesy of WalgreenWalgreen Co. (NYSE: WAG) reported first-quarter fiscal 2013 results before markets opened this morning. The drug store chain…
Paul Ausick |

Walgreen Sales Dive in September

Same-store sales at Walgreen Co. (NYSE: WAG) dropped 7.8% in September, compared with sales in September 2011, from $5.94 billion…
Rite Aid Stumbles as It Looks Forward to Merger With Walgreens
Paul Ausick |

Rite Aid Stumbles as It Looks Forward to Merger With Walgreens

Rite Aid reported disappointing first-quarter fiscal 2017 results before markets opened Thursday morning.
Paul Ausick |

Walgreen’s Misses Estimates, Promises Answer on Offshore Move

Walgreen reported third-quarter fiscal 2014 results before markets opened Tuesday morning and withdrew its fiscal 2016 goals in lieu of…
Mike Sauter |

America’s Most Popular Stores

courtesy of McDonald'sOne half of Americans went to McDonald’s at least once in March, according to location analytics group Placed…
Paul Ausick |

CVS Beats Estimates, Raises EPS Guidance

ThinkstockCVS Caremark Corp. (NYSE: CVS) reported third-quarter 2012 earnings this morning. The pharmacy benefits management and retail sales firm posted…
Rite Aid Treading Water as Regulators Examine Acquisition
Paul Ausick |

Rite Aid Treading Water as Regulators Examine Acquisition

Rite Aid reported third-quarter fiscal 2016 results before markets opened Thursday morning.

Top Gaining Stocks

Cboe Global Markets
CBOE • Vol: 1,568,143
New Pluto Global
PSKY • Vol: 12,285,993
Seagate Technology
STX • Vol: 7,378,346
Oracle
ORCL • Vol: 26,317,675
Datadog
DDOG • Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ • Vol: 4,367,433
Clorox
CLX • Vol: 13,260,523
Stryker
SYK • Vol: 4,519,455
Mohawk Industries
MHK • Vol: 1,859,865
Amgen
AMGN • Vol: 3,818,618